In cases of T2DM, the beneficial effects of (−)-catechin in the treatment of obesity-related diseases were also observed, with enhanced insulin-dependent glucose uptake in differentiated adipocytes [79]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.